#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Tsvetelina Pencheva Hoang Email
VP Research and Development . Marker Therapeutics
Houston, TX
Locationt*****@markertherapeutics.com
Primary EmailHow to contact Tsvetelina Pencheva Hoang
Join and see Tsvetelina's contact info for free!t*****@markertherapeutics.com
Phone
917815****
GROWJO
The Free Company & People Database
Current Roles
Marker Therapeutics
Get all of our best features!
About
We are a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Marker’s cell therapy technology is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor associated antigens (i.e. tumor targets) and kill tumor cells expressing those targets. Once infused into patients, this population of T cells attacks multiple tumor targets and acts to activate the patient’s immune system to produce broad spectrum anti-tumor activity. Because Marker does not genetically engineer its T cells, when compared to current engineered CAR-T and TCR-based approaches, its products (i) are significantly less expensive and easier to manufacture, (ii) appear to be markedly less toxic, and (iii) are associated with meaningful clinical benefit. As a result, Marker believes its portfolio of T cell therapies has a compelling therapeutic product profile, as compared to current gene-modified CAR-T and TCR-based therapies. Marker is also advancing a number of innovative peptide- and gene-based immuno-therapeutics for the treatment of cancer and metastatic disease, including our Folate Receptor Alpha program (TPIV200) for breast and ovarian cancers and our HER2/neu+ peptide antigen program (TPIV100/110) in Phase II clinical trials. In parallel, we are developing a proprietary DNA expression technology named PolyStart™ to improve the ability of the cellular immune system to recognize and destroy diseased cells.Marker Therapeutics Address
4551 Kennedy Commerce DriveHouston, TX
United States